Welcome to our dedicated page for ESTABLISHMENT LABS HOLDINGS SEC filings (Ticker: ESTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ESTABLISHMENT LABS HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ESTABLISHMENT LABS HOLDINGS's regulatory disclosures and financial reporting.
Chacon Quiros Juan Jose reported acquisition or exercise transactions in this Form 4 filing.
ESTABLISHMENT LABS HOLDINGS INC. director Juan Jose Chacon Quiros received a grant of 11,315 Common Shares as a stock unit award under the company’s 2018 Equity Incentive Plan, at a stated price of $0.0000 per share. One-fourth of the shares subject to the award vest on April 24, 2027 and on each one-year anniversary thereafter, contingent on continued service. Following this grant, he holds 56,508 Common Shares directly and 927,504 Common Shares indirectly through Sariel Group Ltd, where he has voting and dispositive power but disclaims beneficial ownership beyond his pecuniary interest.
ESTABLISHMENT LABS HOLDINGS INC. director Nicholas Sheridan Lewin received a grant of stock options covering 19,561 common shares at an exercise price of $66.28 per share, expiring on April 24, 2036. One-fourth of these options vest on April 24, 2027 and on each one-year anniversary thereafter, subject to continued service. Following the transactions, he held 1,079,960 common shares directly and 19,090 common shares indirectly through his spouse, plus the newly granted options.
Harris Taylor C. reported acquisition or exercise transactions in this Form 4 filing.
ESTABLISHMENT LABS HOLDINGS INC. director Harris Taylor C. received two equity awards in the form of stock units representing common shares. One grant covers 1,773 common shares, and another covers 1,949 common shares, both awarded at no cash cost as director compensation under the company’s 2018 Equity Incentive Plan.
The 1,773-share award vests in three equal annual installments on each yearly anniversary of the grant date, subject to continued service. The 1,949-share award vests in full on the earlier of June 24, 2027 or the day before the next annual stockholder meeting, also contingent on ongoing service.
Gillin Leslie reported acquisition or exercise transactions in this Form 4 filing.
ESTABLISHMENT LABS HOLDINGS INC. director Leslie Gillin received 196 common shares as a stock grant on June 30, 2026. The shares were elected in lieu of a quarterly cash retainer under the company’s Outside Director Compensation Policy and issued under the 2018 Equity Incentive Plan, based on a closing price of $85.81 per share. Following this compensation-related award, Gillin directly holds 18,594 common shares.
Custin Ann reported acquisition or exercise transactions in this Form 4 filing.
Establishment Labs Holdings Inc. director Ann Custin received an equity grant of common shares as part of her board compensation. She was awarded 239 common shares, elected in lieu of a quarterly cash retainer under the company’s Outside Director Compensation Policy. The shares were issued under the 2018 Equity Incentive Plan at a reference price of $85.81 per share, based on the closing price on the last trading day of the quarter. Following this grant, Custin directly holds 24,325 common shares of the company.
LEWIN NICHOLAS SHERIDAN reported acquisition or exercise transactions in this Form 4 filing.
Establishment Labs Holdings Inc. director Nicholas Sheridan Lewin received 291 common shares as a stock grant. These shares were elected in lieu of a quarterly cash retainer under the company’s Outside Director Compensation Policy and were issued under the 2018 Equity Incentive Plan, using a reference price of $85.81 per share.
After this grant, Lewin directly holds 1,079,960 common shares. An additional 19,090 common shares are reported as indirectly owned and are held by his spouse.
SCHUTTER EDWARD J reported acquisition or exercise transactions in this Form 4 filing.
Establishment Labs Holdings Inc. director Edward J. Schutter received a grant of 216 common shares on June 30, 2026, valued using a price of $85.81 per share. These shares were elected in lieu of a quarterly cash retainer under the company’s Outside Director Compensation Policy, bringing his direct holdings to 177,952 shares.
Slotkin Bryan reported acquisition or exercise transactions in this Form 4 filing.
ESTABLISHMENT LABS HOLDINGS INC. director Bryan Slotkin reported receiving 189 common shares as compensation. These shares were granted in lieu of a quarterly cash retainer under the company’s Outside Director Compensation Policy, based on a closing share price of $85.81. Following this award, Slotkin directly holds 32,799 common shares.
Harris Taylor C. reported acquisition or exercise transactions in this Form 4 filing.
ESTABLISHMENT LABS HOLDINGS INC. director Harris Taylor C. reported two equity awards of stock units under the company’s 2018 Equity Incentive Plan. One award covers 1,281 stock units, vesting in three equal annual installments on each yearly anniversary of the grant date, subject to continued service. A separate award covers 1,949 stock units, vesting in full on the earlier of June 24, 2027 or the day prior to the company’s next annual meeting of stockholders, also subject to continued service. Following the first transaction, Taylor’s reported direct holdings in common shares were 3,230 shares, and following the second, 1,949 shares are reported in that line item.
ESTABLISHMENT LABS HOLDINGS INC. filed an initial Form 3 for director Harris Taylor C. This filing identifies him as a director but shows no reported transactions or derivative positions. It functions as a baseline disclosure of his status as an insider without detailing specific share holdings.